Skip to content

Aeva Technologies AEVA Net realized gains (losses)

Net realized gains (losses) at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$28K+1,300%
Clearwater Analytics logo
Clearwater AnalyticsCWAN
$0-100%
Voya Financial logo
Voya FinancialVOYA
-$45M-38.5%
Cytokinetics logo
CytokineticsCYTK
$61K
Sixth Street Specialty Lending logo
Sixth Street Specialty LendingTSLX
-$39.26M-3,621%
Old Republic International logo
Old Republic InternationalORI
$85.3M+128%

Other financials

Income statement

See full
Revenue$6.3M+85.9%
Gross profit$1.9M+526%
Operating income-$35.1M-15.5%
Net income-$35.0M-0.3%
EPS (diluted)-$0.56+12.5%

Balance sheet

See full
Cash & equivalents$31.2M+47.0%
Total debt$5.3M+87.4%
Total equity-$12.4M-118%
Total assets$147.3M+28.6%

Cash flow

See full
Operating cash flow-$25.8M+16.1%
CapEx$2.2M+385%
Free cash flow-$28.1M+10.2%

Valuation

See full
Market cap$1.35B+116%
Enterprise value$1.33B+120%
P/S64.5×+3.9×

Profitability

See full
Gross margin-18.5%-7.1pp
Operating margin-630.9%-229pp
Net margin-693.9%-240pp
FCF margin-555.5%-181pp

Returns & leverage

See full
Return on equity-258.4%-589pp
Debt / equity0.4×+0.4×
Current ratio4.1×+1.2×

Where this comes from

Reported directly by Aeva Technologies in its filing.

Tagged under the XBRL concept us-gaap:RealizedInvestmentGainsLosses.

The official record: Aeva Technologies’s 10-K, filed March 21, 2025, on SEC EDGAR. View the filing →

Ask your AI about Aeva Technologies's net realized gains (losses).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aeva Technologies's net realized gains (losses)?
Aeva Technologies (AEVA) reported net realized gains (losses) of $0 in Q4 2024.